Metformin can lower elevated insulin levels associated with type 2 diabetes by inhibiting hepatic gluconeogenesis via AMPK activation, and increases insulin sensitivity and glucose utilization by skeletal muscle and adipose tissue resulting in reduced blood glucose and insulin levels [7], [8], [30]–[32]. Here, INS is linked to type 2 diabetes mellitus.